title: Effects of lidocaine and mexiletine on defibrillation energy requirements in animals treated with flecainide.
abstract: We previously reported that mexiletine alone did not increase the ventricular defibrillation threshold (DFT). However it has been stressed that the interaction of antiarrhythmic drugs may be one of the cause of sudden death in patients taking flecainide or encainide. In the present study, the effect of lidocaine and mexiletine combined with flecainide on DFT was investigated. Experiments were performed on 27 mongrel dogs. Flecainide 2 mg kg(-1) was administered i.v. as a loading dose and repeated for maintenance. Lidocaine (n = 10) or mexiletine (n = 10), was cumulatively administered 15 min later. Saline was administered in control group (n = 7). In these groups, fibrillation/defibrillation trials were repeated. The flecainide concentration ranged from 0.84 to 1.02 microg ml(-1). The lidocaine and mexiletine concentrations increased up to 12.54 and 7.47 microg ml(-1), respectively. DFT15, 15 min after the administration of flecainide, increased from 2.0 to 3.2 J in lidocaine group (mean +/- S.E.M.; P < 0.05), from 2.1 to 3.7 J in mexiletine group (mean +/- S.E.M.; P < 0.05). DFT increased with lidocaine concentrations of 3.42 microg ml(-1) or higher, and mexiletine of 3.60 microg ml(-1) or higher (P < 0.05). In conclusion, both lidocaine and mexiletine elevated the DFT in the dog treated with flecainide, especially with lidocaine in a therapeutic concentration.
authors.affiliation: Department of Anesthesiology, Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Sato
authors.forename: N
authors.initials: N
authors.lastname: Imagawa
mesh_terms: D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000494:pharmacology*; D004285:Dogs; D004554:Electric Countershock; D005424:Flecainide / Q000009:adverse effects / Q000494:pharmacology*; D008012:Lidocaine / Q000494:pharmacology*; D008801:Mexiletine / Q000494:pharmacology*; D014693:Ventricular Fibrillation / Q000139:chemically induced / Q000517:prevention & control*
chemical_list: D000889:Anti-Arrhythmia Agents; D008801:Mexiletine; D008012:Lidocaine; D005424:Flecainide